Zobrazit další navigaci
Celý web BIOTRIN
Předchozí News in July 2012 News in June 2012 News in May 2012 News in April 2012 News in March 2012 News in February 2012 News in January 2012 News in December 2011 News in November 2011 News in October 2011 News in September 2011 News in July 2011 News in June 2011 News in May 2011 News in April 2011 News in March 2011 News in February 2011 News in January 2011 News in December 2010 News in November 2010 News in October 2010 News in September 2010 News in August 2010 News in July 2010 News in June 2010 News in May 2010 News in April 2010 News in March 2010 News in February 2010 News in January 2010 News in December 2009 News in November 2009 News in October 2009 News in September 2009 News in August 2009 News in July 2009 News in June 2009 News in May 2009 News in April 2009 News in March 2009 News in February 2009 News in January 2009 News in December 2008 News in November 2008 News in October 2008 News in September 2008 News in August 2008 News in July 2008 News in June 2008 News in May 2008 News in April 2008 News in March 2008 News in February 2008 News in January 2008 News in December 2007 News in November 2007 News in October 2007 News in September 2007 News in August 2007 News in June 2007 News in May 2007 News in April 2007 News in March 2007 News in February 2007 News in January 2007 News in December 2006 News in November 2006 News in October 2006 News in September 2006 News in August 2006 News in July 2006 News in June 2006 News in May 2006 News in April 2006 News in March 2006 News in February 2006 News in January 2006 News in December 2005 News in November 2005 News in October 2005 News in September 2005 News in August 2005 News in July 2005 News in May 2005 News in April 2005 News in March 2005 News in February 2005 News in January 2005 Global Status of commercialized BIOTECH/GM Crops: 2004 News in December 2004 News in November 2004 News in October 2004 News in September 2004 News in August 2004 Press Release Moratorium to court Project "Gene Therapy" GM food passed as safe Europe accept human cloning Two news story on Moore paper dragon burned Honeybees bring affairs in biotechnology Classical breeding PRODI EXTENDS ETHICS GROUP'S REMIT EU support for biotech Swiss conference How is it with soya? We need to talk Rice with a vitamin and without patents What is new


Commission President Romano Prodi announced this April that he wishes to strengthen the role of the European Group on ethics in science and new technologies (EGE) . The group was set up in 1997 to advise on ethical aspects of science and technologies - not just biotechnologies - in connection with the preparation and implementation of Community legislation.

According to the Commission, the EGE's remit has been amended in order to:

bulletensure that the other Community institutions have access to the group, stipulating that the 'Parliament and the Council can draw the Commission's attention to questions which they consider to be of major interest from the ethical angle.' The group also retains the right to act on its own initiative on questions it considers important;
bullethighlight the fact that the group is independent, multidisciplinary and pluralistic;
bulletextend the term of office from three to four years, while leaving the number of members unchanged at 12;
bulletenhance the working methods of the group, which may for example establish closer links with different ethics committees in the European Union and applicant countries and initiate any studies it deems necessary for preparing its opinions.

In addition, the Commission has appointed new members of the group. 'In order to ensure the coherence and continuity of the groups' work, five of the 12 members served in the previous group,' reports the Commission. 'The balance of disciplines has also been maintained, with one third of the group being lawyers, one third scientists and one third representatives of the social sciences (philosophy and theology) .' French lawyer Noëlle Lenoir remains as Chair of the group.

At the request of President Prodi, the EGE's first task concerns the ethical aspects of the patentability of living matter, in particular inventions involving the use of stem cells from human embryos.

horizontal rule

Reminder to content type on to